#Aduhelm

Congressional Inquiry into Alzheimer’s Drug Faults Its Maker and F.D.A.
Business

Congressional Inquiry into Alzheimer’s Drug Faults Its Maker and F.D.A.

Medicare Officially Limits Coverage of Aduhelm to Patients in Clinical Trials
Business

Medicare Officially Limits Coverage of Aduhelm to Patients in Clinical Trials

Medicare Proposes to Cover Aduhelm Only for Patients in Clinical Trials
Business

Medicare Proposes to Cover Aduhelm Only for Patients in Clinical Trials

Decision Looms That Could Determine Fate of Alzheimer’s Drug
Business

Decision Looms That Could Determine Fate of Alzheimer’s Drug

Biogen Slashes Price of Alzheimer’s Drug Aduhelm, as It Faces Obstacles
Business

Biogen Slashes Price of Alzheimer’s Drug Aduhelm, as It Faces Obstacles

Controversial Alzheimer's drug could cost US $334B'nearly half of DoD budget
Tech

Controversial Alzheimer's drug could cost US $334B'nearly half of DoD budget

Showing 1 to 6 of 6 articles
Popular on TVN
Stay In Touch

All Rights Reserved © 2024